This journal is a peer reviewed, open access journal.
All articles published open access will be immediately and permanently free for everyone to read, download, copy and distribute. Permitted reuse is defined by your choice of one of the following user licenses:Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): for non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.Open Access Publication Fee
As an open access journal with no subscription charges, a fee is payable by the author or research funder to cover the costs associated with publication. This ensures your article will be immediately and permanently free to access by everyone.The open access publication fee for this journal is USD 1000, excluding taxes.
For all articles submitted before 31-Dec-2017, there is a 40% discount off the open access publication fee so authors pay USD 600, excluding taxes.
|Full Price||Discount Price|
valid till 31-Dec-2017
|USD 1000||USD 600|
Funding Body AgreementsElsevier has established agreements with funding bodies, including Wellcome Trust and Research Councils UK. This ensures authors can comply with funding body open access policies and may also be reimbursed for their publication fees.
Author RightsFor open access publishing this journal uses an exclusive licensing agreement. Authors will retain copyright alongside scholarly usage rights and Elsevier will be granted publishing and distribution rights.
This journal publishes 1 volume a year and follows an article-based publishing model.